These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2080604)

  • 21. [Our experience in using the Hungarian biphasic systemic contraceptive anteovin].
    Vasilev D; Katsarova M
    Akush Ginekol (Sofiia); 1990; 29(2):78-81. PubMed ID: 2400066
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case report with hemolytic uremic syndrome by a oral contraceptive, and its clinical and pathological reviews (author's transl)].
    Fukushima K; Yamagata Y; Taguchi T; Matsuo K; Koga N; Takebayashi S
    Nihon Jinzo Gakkai Shi; 1981 Apr; 23(4):399-410. PubMed ID: 7328888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral contraceptive interaction with cyclosporin.
    Deray G; le Hoang P; Cacoub P; Assogba U; Grippon P; Baumelou A
    Lancet; 1987 Jan; 1(8525):158-9. PubMed ID: 2879990
    [No Abstract]   [Full Text] [Related]  

  • 24. [Risks of postcoital contraception using a d-norgestrel-ethinyl estradiol combination].
    Welti H; Nguyen Duy N; Zufferey MM
    Ther Umsch; 1986 May; 43(5):438-40. PubMed ID: 3726780
    [No Abstract]   [Full Text] [Related]  

  • 25. Results of the multilateral study of Tri-Regol tablet.
    Seregély G
    Ther Hung; 1991; 39(3):136-41. PubMed ID: 1840164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenteric vein thrombosis associated with oral contraceptive administration during pregnancy.
    Friedman M; Zimmer EZ; Graubard ZG
    Ann Chir Gynaecol; 1984; 73(5):296-8. PubMed ID: 6524863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in plasma HDL-cholesterol in women using oral contraceptives in Kenya.
    Maina FW; Sekadde-Kigondu CB; Ojwang PJ; Mati JK
    East Afr Med J; 1987 Jul; 64(7):442-7. PubMed ID: 3691360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change to Tri-Regol from other oral contraceptives.
    Garamvölgyi G
    Ther Hung; 1991; 39(3):122-4. PubMed ID: 1818425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum prolactin levels in women using oral contraceptives (Gravistat)].
    Mikrut W; Jeske W
    Ginekol Pol; 1985 Oct; 56(10):620-3. PubMed ID: 4092990
    [No Abstract]   [Full Text] [Related]  

  • 30. Observations with a tri-phasic oral contraceptive (Tri-Regol) in everyday clinical practice.
    Kovács I; Novák K; Pomázi L; Hammersberg E
    Ther Hung; 1992; 40(2):86-9. PubMed ID: 1462283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observations with anteovin in family planning advisory unit.
    Domány Z
    Ther Hung; 1988; 36(1):29-33. PubMed ID: 3388289
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinico-laboratory research on the pharmacodynamic characteristics of Rigevidon].
    Korkhov VV; Nikanorova SA
    Farmakol Toksikol; 1987; 50(1):97-100. PubMed ID: 3556564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carpal tunnel syndrome caused by oral contraceptives].
    Tordesillas Lia C; Rodríguez de la Serna A; Pradas Orozco J; Illa Sendra I
    Rev Clin Esp; 1985 Jun; 177(1):46. PubMed ID: 4035041
    [No Abstract]   [Full Text] [Related]  

  • 34. Results of a multilateral study with Anteovin.
    Seregély G
    Ther Hung; 1990; 38(4):160-5. PubMed ID: 2094055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
    Vesper VB; Feustel S
    Zentralbl Gynakol; 1988; 110(4):241-5. PubMed ID: 2453102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of the secondary effects associated with taking a triphasic anti-ovulatory contraceptive].
    Vekemans M
    Rev Med Brux; 1984 Jan; 5(1):13-9. PubMed ID: 6701404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormonal contraception and focal nodular hyperplasia].
    Wedig MP; Altmann C
    Zentralbl Gynakol; 1991; 113(24):1399-402. PubMed ID: 1667053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of two low-dose oral contraceptives on erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities.
    Jendryczko A; Tomala J; Janosz P
    Zentralbl Gynakol; 1993; 115(11):469-72. PubMed ID: 8296490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expectant management of focal nodular hyperplasia during pregnancy. A case report.
    Kivnick S; Greenspoon JS; Kanter MH; Gee C; Fullman HJ
    J Reprod Med; 1992 Apr; 37(4):367-71. PubMed ID: 1593563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythema multiforme.
    Manganaro AM
    Gen Dent; 1996; 44(2):164-6. PubMed ID: 8690267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.